1. Home
  2. BVFL vs NERV Comparison

BVFL vs NERV Comparison

Compare BVFL & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BVFL

BV Financial Inc.

HOLD

Current Price

$22.25

Market Cap

176.4M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

BUY

Current Price

$2.24

Market Cap

166.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BVFL
NERV
Founded
1873
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.4M
166.4M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
BVFL
NERV
Price
$22.25
$2.24
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
14.8K
★ 107.4K
Earning Date
10-23-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.19
N/A
EPS
★ 0.55
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.75
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.13
$2.18
52 Week High
$22.70
$8.80

Technical Indicators

Market Signals
Indicator
BVFL
NERV
Relative Strength Index (RSI) 54.05 25.53
Support Level $20.36 N/A
Resistance Level $21.86 $5.69
Average True Range (ATR) 0.44 0.26
MACD 0.05 -0.01
Stochastic Oscillator 49.09 0.78

Price Performance

Historical Comparison
BVFL
NERV

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: